Marc Coucke

Marck Coucke sponsoring Omega Pharma-Lotto in February 2010

Marc Coucke (born Ghent in 1965) is a Belgian businessman, inventor and media figure. Founder of former BEL20 pharmaceutical company Omega Pharma, he has spread his business interests across several sectors including art, through his company Kamacoucka, and sports, through the co-ownership and sponsorship of the UCI ProTeam Etixx–Quick-Step cycling team, sponsorship of French Ligue 1 side Lille OSC and in the capacity of chairman of Belgian Pro League team K V Oostende.

Biography

Marc Coucke studied at St Barbara College in Ghent before attending the University of Ghent (Ghent, Belgium) where he studied pharmocology. Later he obtained a Master in General Management from the Vlerick Leuven Gent Management School.

Marc Coucke, portrait by the Belgian artist Willy Bosschem

Biography

In 1987 with Yvan Vindevogel, he founded Omega Pharma a Belgian pharmaceuticals company that grew rapidly and in 2006 employed three thousand people whilst operating in thirty countries.[1][2] He remained Chief Executive Officer of Omega Pharma until 30 September 2006 returning to the post in March 2008. Whilst his business profile represents considerable achievement there have been high publicised failures that include the launch of Omega Pharma's E-Waves phone Chip in 2008. It was withdrawn shortly after release as it did not work.

In 2007, he was featured as a member of the jury in the television show De bedenkers.In 2013 he became the major shareholder and chairman of K V Oostende.

Personal

Marc Coucke is married and has two daughters. He lives in the newly renovated eighteenth century Castle Mijleke near Merelbeke in east Flanders[3]

References

  1. ↑ "Omega Pharma: History". Retrieved 14 January 2013.
  2. ↑ "Annual Report 2010" (PDF). Omega Pharma. Retrieved 22 April 2011.
  3. ↑ Greet Lefèvre (2009-12-10). "Belgian Pearls: Belgian Castles for sale". Belgianpearls.blogspot.co.uk. Retrieved 2013-11-30.
This article is issued from Wikipedia - version of the 3/14/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.